Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gussie Beech"'
Publikováno v:
Airway pharmacology and treatment.
Autor:
Iain Kilty, Dave Singh, Eilise M. Ryan, Ppeter J. Barnes, Gussie Beech, Richard D. Emes, Irina Tcherniaeva, Louise E. Donnelly, Sarah R. Walmsley, Moira K. B. Whyte, Jadwiga A. Wedzicha, Martin A. Bewley, Umme Kolsum, Joby Cole, Jennifer L. Marshall, William L. Rumsey, Richard C. Budd, Yolanda Sanchez, Christopher E. Brightling, Gavin C. Donaldson, Gguy A.M. Berbers, David H. Dockrell, Paul Collini
Publikováno v:
Bewley, M A, Budd, R C, Ryan, E, Cole, J, Collini, P, Marshall, J, Kolsum, U, Beech, G, Emes, R D, Tcherniaeva, I, Berbers, G A M, Walmsley, S R, Donaldson, G, Wedzicha, J A, Kilty, I, Rumsey, W, Sanchez, Y, Brightling, C E, Donnelly, L E, Barnes, P J, Singh, D & Whyte, M K B & Dockrell, D H 2018, ' Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease is Enhanced by Nrf2 Agonists ', American Journal of Respiratory and Critical Care Medicine, vol. 198, no. 6, pp. 739-750 . https://doi.org/10.1164/rccm.201705-0903OC
Bewley, M A, Budd, R C, Ryan, E, Cole, J, Collini, P, Marshall, J, Kolsum, U, Beech, G, Emes, R D, Tcherniaeva, I, Berbers, G A M, Walmsley, S R, Donaldson, G, Wedzicha, J A, Kilty, I, Rumsey, W, Sanchez, Y, Brightling, C, Donnelly, L E, Barnes, P J, Singh, D, Whyte, M K B & Dockrell, D H 2018, ' Opsonic phagocytosis in chronic obstructive pulmonary disease is enhanced by Nrf2 agonists ', American Journal of Respiratory and Critical Care Medicine . https://doi.org/10.1164/rccm.201705-0903OC
Bewley, M A, Budd, R C, Ryan, E, Cole, J, Collini, P, Marshall, J, Kolsum, U, Beech, G, Emes, R D, Tcherniaeva, I, Berbers, G A M, Walmsley, S R, Donaldson, G, Wedzicha, J A, Kilty, I, Rumsey, W, Sanchez, Y, Brightling, C, Donnelly, L E, Barnes, P J, Singh, D, Whyte, M K B & Dockrell, D H 2018, ' Opsonic phagocytosis in chronic obstructive pulmonary disease is enhanced by Nrf2 agonists ', American Journal of Respiratory and Critical Care Medicine . https://doi.org/10.1164/rccm.201705-0903OC
Rationale: Previous studies have identified defects in bacterial phagocytosis by alveolar macrophages (AMs) in patients with chronic obstructive pulmonary disease (COPD), but the mechanisms and clinical consequences remain incompletely defined.Object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ede7f3b1e46ae120abd9a1e44f2fc73
https://www.pure.ed.ac.uk/ws/files/67945656/AJRCCM_Online_Sup_TEXT_SUB.docx
https://www.pure.ed.ac.uk/ws/files/67945656/AJRCCM_Online_Sup_TEXT_SUB.docx
Publikováno v:
Southworth, T, Beech, G, Foden, P, Kolsum, U & Singh, D 2018, ' The reproducibility of COPD blood eosinophil counts ', European Respiratory Journal . https://doi.org/10.1183/13993003.00427-2018
Background: Clinical trials have shown that higher blood eosinophil counts in COPD patients predict a greater effect of inhaled corticosteroids (ICS) on exacerbation prevention; ICS effects increase incrementally with higher eosinophil counts. There